[1] SCHMITT SK. Osteomyelitis.Infect Dis Clin North Am.2017; 31(2):325-338.
[2] BIRT MC, ANDERSON DW, BRUCE TOBY E, et al. Osteomyelitis: Recent advances in pathophysiology and therapeutic strategies.J Orthop.2017;14(1):45-52.
[3] KUBES JN, FRIDKIN SK. Factors affecting the geographic variability of antibiotic-resistant healthcare-associated infections in the United States using the CDC Antibiotic Resistance Patient Safety Atlas.Infect Control Hosp Epidemiol. 2019;40(5):597-599.
[4] SALGADO-PABÓN W, SCHLIEVERT PM. Models matter: the search for an effective Staphylococcus aureus vaccine.Nat Rev Microbiol. 2014;12(8):585-591.
[5] HORST SA, HOERR V, BEINEKE A, et al. A Novel Mouse Model of Staphylococcus aureus Chronic Osteomyelitis That Closely Mimics the Human Infection.Am J Pathol. 2012; 181(4):1206-1214.
[6] DELEO FR, CHAMBERS HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era.J Clin Invest. 2009;119(9):2464-2474.
[7] HOHMER EA, KIRKHAM J, WOOD D, et al. Long bone defect models for tissue engineering applications: criteria for choice.J Tissue Eng Part B Rev.2010;16(2): 263-271.
[8] PERLMAN RL. Mouse Models of Human Disease: An Evolutionary Perspective.Evol Med Public Health. 2016; 2016(1):170-176.
[9] FOWLER VG, PROCTOR RA. Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect. 2014;20(6): 66-75.
[10] PEARCE AI, RICHARDS RG, MILZ S, et al. Animal models for implant biomaterial research in bone: A review. Eur Cell Mater.2007;13(3):1-10.
[11] MAPARA M, THOMAS BS, BHAT KM. Rabbit as an animal model for experimental research.J Dent Res J.2012;9(1): 111-118.
[12] MILLER RJ, THOMPSON JM, ZHENG J, et al. In Vivo Bioluminescence Imaging in a Rabbit Model of Orthopaedic Implant-Associated Infection to Monitor Efficacy of an Antibiotic-Releasing Coating.J Bone Joint Surg Am. 2019; 101(4):e12.
[13] ESTEVES PJ, ABRANTES J, BALDAUF HM, et al. Author Correction: The wide utility of rabbits as models of human diseases.Exp Mol Med. 2019;51(7):71.
[14] BOTTAGISIO M, COMAN C, LOVATI AB. Animal models of orthopaedic infections. A review of rabbit models used to induce long bone bacterial infections.J Med Microbiol. 2019; 68(4):506-537.
[15] HARRASSER N, GORKOTTE J, OBERMEIER A, et al. A new model of implant-related osteomyelitis in the metaphysis of rat tibiae.BMC Musculoskelet Disord. 2016;17:152.
[16] WANG Q, CHEN C, LIU W, et al. Levofloxacin loaded mesoporous silica microspheres/nano-hydroxyapatite/ polyurethane composite scaffold for the treatment of chronic osteomyelitis with bone defects. Scientific Reports. 2017,7: 41808.
[17] TUCHSCHERR L, PÖLLATH C, SIEGMUND A, et al. Clinical S. aureus Isolates Vary in Their Virulence to Promote Adaptation to the Host.Toxins (Basel). 2019;11(3). pii: E135.
[18] WANG Y, LIU Q, LIU Q, et al. Phylogenetic analysis and virulence determinant of the host-adapted Staphylococcus aureus lineage ST188 in China.Emerg Microbes Infect. 2018; 7(1):45.
[19] NISHITANI K, SUTIPORNPALANGKUL W, DE MESY BENTLEY KL, et al. Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors.J Orthop Res. 2015;33(9):1311-1319.
[20] SWEENEY E, LOVERING AM, BOWKER KE, et al. An in vitro biofilm model of Staphylococcus aureus infection of bone.J Letters in Applied Microbiology.2019;68(4):294-302.
[21] SHIELS SM, BEDIGREW KM, WENKE JC. Development of a hematogenous implant-related infection in a rat model.BMC Musculoskelet Disord. 2015;16:255.
[22] LI D, GROMOV K, SØBALLE K, et al. Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity.J Orthop Res. 2008;26(1):96-105.
[23] SEIDL K, BAYER AS, MCKINNELL JA, et al. In vitro endothelial cell damage is positively correlated with enhanced virulence and poor vancomycin responsiveness in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.J Cellular Microbiology.2011;13(10):1530-1541.
[24] MAISEM L, ANNE-CATRIN U, LOWY FD, et al. Evolutionary Trade-Offs Underlie the Multi-faceted Virulence of Staphylococcus aureus.J PLOS Biology.2015;13(9):e1002229-.
[25] BURR DB, COOK LT, CILENTO EV, et al. A method for radiographically measuring true femoral rotation.Clin Orthop Relat Res. 1982;(167):139-144.
[26] EMSLIE KR, OZANNE NR, NADE SM. Acute haematogenous osteomyelitis: An experimental model.J Pathol. 1983;141(2):157-167.
[27] POULTSIDES LA, PAPATHEODOROU LK, KARACHALIOS TS, et al. Novel model for studying hematogenous infection in an experimental setting of implant-related infection by a community-acquired methicillin-resistant S. aureus Strain.J Orthop Res. 2008;26(10):1355-1362.
[28] SVENSSON S, SUSKA F, EMANUELSSON L, et al. Osseointegration of titanium with an antimicrobial nanostructured noble metal coating.Nanomedicine. 2013; 9(7):1048-1056.
[29] ODEKERKEN JC, ARTS JJ, SURTEL DA, et al.A rabbit osteomyelitis model for the longitudinal assessment of early post-operative implant infections.J Orthop Surg Res. 2013;8:38.
[30] ASHHURST DE, HOGG J, PERREN SM.A method for making reproducible experimental fractures of the rabbit tibia.Injury. 1982;14(3):236-242.
[31] SMELTZER MS, THOMAS JR, HICKRAON SG, et al. Characterization of a rabbit model of staphylococcal osteomyelitis.J Orthop Res. 1997;15(3):414-421.
[32] MISTRY S, ROY S, MAITRA NJ, et al. A novel, multi-barrier, drug eluting calcium sulfate/biphasic calcium phosphate biodegradable composite bone cement for treatment of experimental MRSA osteomyelitis in rabbit model.J Control Release. 2016;239:169-181.
[33] HAMEL A, CAILLON J, JACQUELINE C, et al. Internal device decreases antibiotic’s efficacy on experimental osteomyelitis. J Child Orthop. 2008;2(3):239-243.
[34] TER BOO GA, ARENS D, METSEMAKERS WJ, et al. Injectable gentamicin-loaded thermo-responsive hyalu-ronic acid derivative prevents infection in a rabbit model.J Acta Biomater.2016;43(7):185-194.
[35] LOVATI AB, ROMANÒ CL, BOTTAGISIO M, et al.Modeling Staphylococcus epidermidis-Induced Non-Unions: Subclinical and Clinical Evidence in Rats.PLoS One. 2016;11(1): e0147447.
[36] ZHANG X, MA YF, WANG L, et al. A rabbit model of implant-related osteomyelitis inoculated with biofilm after open femoral fracture.J Exp Ther Med.2017;14(5): 4995-5001.
[37] GAJDOBRANSKI D, MITKOVIC M, NADA VUCKOVIĆ, et al. Influence of Different Methods of Internal Bone Fixation on Characteristics of Bone Callus in Experimental Animals.J Srpski arhiv za celokupno lekarstvo.2014;142(1-2):40-47.
[38] GAO J, HUANG G, LIU G, et al.A biodegradable antibiotic-eluting PLGA nanofiber-loaded deproteinized bone for treatment of infected rabbit bone defects.J Biomater Appl. 2016;31(2):241–249.
[39] TROMBETTA RYAN P, NINOMIYA MARK J, EL-ATAWNEH IHAB M, et al. Calcium Phosphate Spacers for the Local Delivery of Sitafloxacin and Rifampin to Treat Orthopedic Infections: Efficacy and Proof of Concept in a Mouse Model of Single-Stage Revision of Device-Associated Osteomyelitis.J Pharmaceutics.2019;11(2):94.
[40] ZAHAR A, KOCSIS G, CITAK M, et al. Use of antibiotic- impregnated bone grafts in a rabbit osteomyelitis model.J Technol Heal Care.2017;25(5):929-938.
[41] SAEED K, MCLAREN AC, SCHWARZ EM, et al. 2018 international consensus meeting on musculoskeletal infection: Summary from the biofilm workgroup and consensus on biofilm related musculoskeletal infections.J Orthop Res. 2019; 37(5):1007-1017.
[42] SURDU-BOB CC, COMAN C, BARBUCEANU F, et al. The influence of foreign body surface area on the outcome of chronic osteomyelitis.J Med Eng Phys.2016;38(9):870–876.
[43] RAIC A, RIEDEL S, KEMMLING E, et al.Biomimetic 3D in vitro model of biofilm triggered osteomyelitis for investigating hematopoiesis during bone marrow infections.J Acta Biomater. 2018;73(4):250-262.
[44] AFZELIUS P, NIELSEN OL, SCHØNHEYDER HC, et al. An untapped potential for imaging of peripheral osteomyelitis in paediatrics using [18 F]FDG PET/CT-the inference from a juvenile porcine model.EJNMMI Res. 2019;9(1):29.
[45] KOEFOED M, ITO H, GROMOV K, et al. Biological Effects of rAAV-caAlk2 Coating on Structural Allograft healing.Molecular Therapy.2005;12(2):212-218.
|